COMMUNIQUÉS West-GlobeNewswire

Lundbeck delivers its best financial results following 10% revenue growth and 117% growth in net profit
07/02/2018
Valby, Denmark, 2018-02-07 07:48 CET (GLOBE NEWSWIRE) -- HIGHLIGHTS Revenue reached DKK 17,234 million in 2017 representing an increase of 10% (12% in local currencies) compared to 2016 Revenue of Abilify Maintena ® [...]
Zealand reports royalty revenue for the fourth quarter of 2017
07/02/2018
Company announcement - No. 7/2018 Zealand reports royalty revenue for the fourth quarter of 2017 Zealand reports royalty revenue of DKK 11.3 million/USD 1.8 million for Q4 2017 The revenue is based on total net sales of [...]
PUBLICATION IN ACCORDANCE WITH ARTICLE 14 OF THE BELGIAN LAW OF 2 MAY 2007 REGARDING THE PUBLICATION OF MAJOR SHAREHOLDINGS (THE "TRANSPARENCY LAW")
07/02/2018
REGULATED INFORMATION GHENT, Belgium, 7 February 2018 - Ablynx [Euronext Brussels and Nasdaq: ABLX] today announced, in accordance with Article 14 of the Belgian Law of 2 May 2007 regarding the publication of major [...]
Double-digit growth in revenue and earnings – delivered on guidance
07/02/2018
In 2017, revenue increased by 11% to DKK 9,585 million. Organic growth was 8% EBITA reached DKK 1,744 million, equivalent to a 10% increase, based on strong execution in both GN Hearing and GN Audio Strong cash [...]
PUBLICATION IN ACCORDANCE WITH ARTICLE 14 OF THE BELGIAN LAW OF 2 MAY 2007 REGARDING THE PUBLICATION OF MAJOR SHAREHOLDINGS (THE "TRANSPARENCY LAW")
07/02/2018
REGULATED INFORMATION GHENT, Belgium, 7 February 2018 - Ablynx [Euronext Brussels and Nasdaq: ABLX] today announced, in accordance with Article 14 of the Belgian Law of 2 May 2007 regarding the publication of major [...]
ABLYNX ANNOUNCES BOARD CHANGES
07/02/2018
GHENT, Belgium, 7 February 2018 - Ablynx NV [Euronext Brussels and Nasdaq: ABLX] today announced that Dr Bo Jesper Hansen, acting as permanent representative of Orfacare Consulting GmbH, has decided to resign from the [...]
Targovax announces completion of safety lead-in and preliminary immune activation data in ONCOS-102 trial in mesothelioma
07/02/2018
Oslo, Norway, 7 February 2018 - Targovax ASA (OSE: TRVX), a clinical stage company focused on developing immuno-oncology therapies to target solid tumors, today announces completion of the safety lead-in cohort and [...]
Fagron turnover increased by 3.6% to € 436.9 million and net profit increased to € 47.0 million
07/02/2018
Regulated information | Consolidated results for the 2017 financial year Nazareth (Belgium) / Rotterdam (The Netherlands), 7 February 2018 Fagron turnover increased by 3.6% to € 436.9 million and net profit increased to [...]
Addex Appoints Jean-Philippe Rocher as Co-Head of Discovery and Member of the Executive Management
07/02/2018
Geneva, Switzerland, 7 February 2018 - Addex Therapeutics (SIX: ADXN), a leading company pioneering allosteric modulation-based drug discovery and development, announced today the appointment of Jean-Philippe Rocher, [...]
Cannabis Wheaton Income Corp. Reminds Warrant Holders of February 15, 2018 Expiry Date
07/02/2018
NOT FOR DISTRIBUTION TO UNITED STATES NEWS WIRE SERVICES OR FOR DISSEMINATION TO UNITED STATES VANCOUVER, British Columbia, Feb. 07, 2018 (GLOBE NEWSWIRE) -- Cannabis Wheaton Income Corp. (d/b/a Wheaton Income) (TSX.V: [...]
Arcturus Therapeutics Issues Statement
07/02/2018
SAN DIEGO, Feb. 06, 2018 (GLOBE NEWSWIRE) -- Arcturus Therapeutics Ltd. (NASDAQ: ARCT ), a leading RNA medicines company, today issued the following statement in response to the 13D filing issued by Joseph E. Payne: We [...]
MacroGenics to Participate in Two Upcoming Investor Conferences
06/02/2018
ROCKVILLE, MD, Feb. 06, 2018 (GLOBE NEWSWIRE) -- MacroGenics, Inc. (Nasdaq: MGNX), a clinical-stage biopharmaceutical company focused on discovering and developing innovative monoclonal antibody-based therapeutics for [...]
Adherium Investor Conference Call
06/02/2018
SAN MATEO, Calif., Feb. 06, 2018 (GLOBE NEWSWIRE) -- Adherium (ASX:ADR), a digital health company that improves medication adherence and patient outcomes, will host a conference call on Wednesday, February 7, 2018 at 6: [...]
Shawn Langer Acquires Common Shares of Vaxil Bio Ltd.
06/02/2018
TORONTO, Feb. 06, 2018 (GLOBE NEWSWIRE) -- Shawn Langer announces that on January 26, 2018, he acquired (the " Acquisition ") by way of private placement ownership over 4,985,000 units (" Units ") of Vaxil Bio Ltd. ( [...]
Osiris Appoints Willi Miesch to its Board of Directors, Change in CEO
06/02/2018
COLUMBIA, Md., Feb. 06, 2018 (GLOBE NEWSWIRE) -- Osiris Therapeutics, Inc. (Pink Sheets:OSIR) is pleased to announce that its Board of Directors, at a Board Meeting on February 6 th , 2018, appointed Mr. Willi Miesch as [...]
Pernix Announces Appointment of Lead Independent Director and Key Management Team Promotion
06/02/2018
Director John R. Leone Named as the Company’s Lead Independent Director Angus Smith Promoted to Senior Vice President, Chief Business Officer and Principal Financial Officer MORRISTOWN, N.J., Feb. 06, 2018 (GLOBE [...]
HealthEquity Reports Year-End Sales Metrics
06/02/2018
DRAPER, Utah, Feb. 06, 2018 (GLOBE NEWSWIRE) -- HealthEquity, Inc. (NASDAQ: HQY ) ("HealthEquity" or the "Company"), one of the nation's largest health savings account ("HSA") custodians, today announced HSA Member and [...]
Myriad Genetics Reports Fiscal Second-Quarter 2018 Financial Results
06/02/2018
Total Revenues of $194.0 Million GAAP Diluted EPS of $0.45 and Adjusted EPS of $0.31 Up 19 Percent Company Raises Financial Guidance for Fiscal Year 2018 SALT LAKE CITY, Feb. 06, 2018 (GLOBE NEWSWIRE) -- Myriad Genetics [...]
Misonix Reports Record Second Quarter Revenue
06/02/2018
FARMINGDALE, N.Y., Feb. 06, 2018 (GLOBE NEWSWIRE) -- Misonix, Inc. (Nasdaq: MSON ) (“Misonix” or the “Company”), a provider of minimally invasive therapeutic ultrasonic medical devices that enhance clinical outcomes, [...]

Pages